SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-022978
Filing Date
2021-11-12
Accepted
2021-11-12 08:07:58
Documents
70
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ardx-20210930.htm   iXBRL 10-Q 1664666
2 EX-31.1 ardx-20210930xex311.htm EX-31.1 8418
3 EX-31.2 ardx-20210930xex312.htm EX-31.2 8406
4 EX-32.1 ardx-20210930xex321.htm EX-32.1 5714
10 ardx-20210930_g1.jpg GRAPHIC 75659
  Complete submission text file 0001628280-21-022978.txt   7042839

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20210930.xsd EX-101.SCH 43417
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ardx-20210930_cal.xml EX-101.CAL 59990
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ardx-20210930_def.xml EX-101.DEF 232175
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20210930_lab.xml EX-101.LAB 584401
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20210930_pre.xml EX-101.PRE 385371
11 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20210930_htm.xml XML 1063432
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 211399774
SIC: 2834 Pharmaceutical Preparations